scispace - formally typeset
M

Matthias Altmeyer

Researcher at University of Zurich

Publications -  83
Citations -  6440

Matthias Altmeyer is an academic researcher from University of Zurich. The author has contributed to research in topics: DNA repair & DNA damage. The author has an hindex of 31, co-authored 75 publications receiving 5055 citations. Previous affiliations of Matthias Altmeyer include MESA+ Institute for Nanotechnology & University of Copenhagen.

Papers
More filters
Journal ArticleDOI

Biomolecular condensates at sites of DNA damage: More than just a phase

TL;DR: In this article, the authors discuss the cooperative potential between clustered stoichiometric binding and phase separation in the context of genome integrity maintenance and highlight the potential to balance structural specificity with favorable physicochemical properties relevant for the regulation and function of multilayered nuclear condensates.
Book ChapterDOI

Cell Cycle Resolved Measurements of Poly(ADP-Ribose) Formation and DNA Damage Signaling by Quantitative Image-Based Cytometry

TL;DR: It is illustrated how this technique can be used to assess the dynamics of the cellular response to oxidative damage as well as to PARP inhibitor-induced genotoxicity in a cell cycle resolved manner.

Magnetic manipulation of bacteria in microfluidics

TL;DR: In this paper, the U-turn trajectory of individual magneto-tactic bacteria (MTB) under reversal of the magnetic field, as a function of the field strength, was measured.
Patent

System and method for superheating and/or supercooling of liquids and use of the system and/or method

TL;DR: In this article, the authors present a system and method for superheating and/or supercooling of liquids and use of the system and or method, wherein the liquid is within a capillary tube, wherein there is at least one heating and or cooling means for heating the liquid above boiling point of the liquid at ambient pressure or cooling the liquid below freezing point of a liquid under ambient pressure.
Journal ArticleDOI

Identifying ADP-ribosylation targets by chemical genetics

TL;DR: Inhibitors of PARylation show promising effects either as monotherapeutic agents or as chemo- or radiosensitizers to support classical DNA damaging cancer therapies.